Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
Business

AI Is Supercharging Drug Development. The Tech is Slashing Early Research Costs and Timelines by Up to 70%

A proprietary survey conducted by investment bank TD Cowen and reported by Axios found that AI-powered tools are cutting preclinical drug development costs and timelines by as much as 70%. (Credit: Lou Benoist/AFP via Getty Images)

Artificial intelligence is rapidly transforming the pharmaceutical industry, dramatically reducing the time and cost required to develop new medicines before they ever reach human testing, according to a new survey.

A proprietary survey conducted by investment bank TD Cowen and reported by Axios found that AI-powered tools are cutting preclinical drug development costs and timelines by as much as 70%.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.